From Cancer Imaging to Quantum Computing: NVision’s Molecular Qubit Breakthrough

Forbes profiled NVision’s $55 million Series B financing round, led by Abbott, and the company’s efforts to scale its quantum-enhanced metabolic imaging platform. The article highlights how POLARIS boosts MRI signals by more than 10,000 times, enabling researchers to visualize tumor metabolism and assess treatment response within days rather than months. It also outlines NVision’s plans to expand to 20 research centers worldwide and apply its molecular quantum technology to drug discovery and development.

Read the full article on Forbes.com ↗

‍